Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Results of Different Myocardial Protection Techniques in Aortic Stenosis

  • Lee, Jung Hee (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jeong, Dong Seop (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Sung, Kiick (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Wook Sung (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Young Tak (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Pyo Won (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2014.09.11
  • Accepted : 2014.12.03
  • Published : 2015.06.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Hypertrophied myocardium is especially vulnerable to ischemic injury. This study aimed to compare the early and late clinical outcomes of three different methods of myocardial protection in patients with aortic stenosis. Methods: This retrospective study included 225 consecutive patients (mean age, 65{\pm}10 years; 123 males) with severe aortic stenosis who underwent aortic valve replacement. Patients were excluded if they had coronary artery disease, an ejection fraction <50%, more than mild aortic regurgitation, or endocarditis. The patients were divided into three groups: group A, which was treated with antegrade and retrograde cold blood cardioplegia; group B, which was treated with antegrade crystalloid cardioplegia using histidine-tryptophan-ketoglutarate (HTK) solution; and group C, treated with retrograde cold blood cardioplegia. Results: Group A contained 70 patients (31.1%), group B contained 74 patients (32.9%), and group C contained 81 patients (36%). The three groups showed significant differences with regard to the proportion of patients with a New York Heart Association functional classification ${\geq}III$ (p=0.035), N-terminal pro-brain natriuretic peptide levels (p=0.042), ejection fraction (p=0.035), left ventricular dimensions (p<0.001), left ventricular mass index (p<0.001), and right ventricular systolic pressure (p <0.001). Differences in cardiopulmonary bypass time (p=0.532) and aortic cross-clamp time (p=0.48) among the three groups were not statistically significant. During postoperative recovery, no significant differences were found regarding the use of inotropes (p=0.328), mechanical support (n=0), arrhythmias (atrial fibrillation, p=0.347; non-sustained ventricular tachycardia, p=0.1), and ventilator support time (p=0.162). No operative mortality occurred. Similarly, no significant differences were found in long-term outcomes. Conclusion: Although the three groups showed some significant differences with regard to patient characteristics, both antegrade crystalloid cardioplegia with HTK solution and retrograde cold blood cardioplegia led to early and late clinical results similar to those achieved with combined antegrade and retrograde cold blood cardioplegia.

Keywords

References

  1. Lotto AA, Ascione R, Caputo M, Bryan AJ, Angelini GD, Suleiman MS. Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery. Ann Thorac Surg 2003;76:1227-33. https://doi.org/10.1016/S0003-4975(03)00840-3
  2. Suleiman MS, Caputo M, Ascione R, et al. Metabolic differences between hearts of patients with aortic valve disease and hearts of patients with ischaemic disease. J Mol Cell Cardiol 1998;30:2519-23. https://doi.org/10.1006/jmcc.1998.0814
  3. Raja Y, Routledge HC, Doshi SN. Coronary stenting for iatrogenic stenosis of the left main coronary artery post-aortic valve replacement: an alternative treatment? Eur J Cardiothorac Surg 2011;39:398-400. https://doi.org/10.1016/j.ejcts.2010.07.001
  4. Ruengsakulrach P, Buxton BF. Anatomic and hemodynamic considerations influencing the efficiency of retrograde cardioplegia. Ann Thorac Surg 2001;71:1389-95. https://doi.org/10.1016/S0003-4975(00)01991-3
  5. Chitwood WR Jr, Wixon CL, Norton TO, Lust RM. Complex valve operations: antegrade versus retrograde cardioplegia? Ann Thorac Surg 1995;60:815-8. https://doi.org/10.1016/0003-4975(95)00231-9
  6. Barner HB. Blood cardioplegia: a review and comparison with crystalloid cardioplegia. Ann Thorac Surg 1991;52:1354-67. https://doi.org/10.1016/0003-4975(91)90034-N
  7. Vahasilta T, Malmberg M, Saraste A, et al. Cardiomyocyte apoptosis after antegrade and retrograde cardioplegia during aortic valve surgery. Ann Thorac Surg 2011;92:1351-7. https://doi.org/10.1016/j.athoracsur.2011.05.065
  8. Guru V, Omura J, Alghamdi AA, Weisel R, Fremes SE. Is blood superior to crystalloid cardioplegia?: a meta-analysis of randomized clinical trials. Circulation 2006;114(1 Suppl):I331-8.
  9. Coughlin TR, Levitsky S, O'Donoghue M, et al. Evaluation of hypothermic cardioplegia in ventricular hypertrophy. Circulation 1979;60(2 Pt 2):164-9. https://doi.org/10.1161/01.CIR.60.1.164
  10. Rajappan K, Rimoldi OE, Dutka DP, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002;105:470-6. https://doi.org/10.1161/hc0402.102931
  11. Friehs I, del Nido PJ. Increased susceptibility of hypertrophied hearts to ischemic injury. Ann Thorac Surg 2003;75:S678-84. https://doi.org/10.1016/S0003-4975(02)04692-1
  12. Sink JD, Pellom GL, Currie WD, et al. Response of hypertrophied myocardium to ischemia: correlation with biochemical and physiological parameters. J Thorac Cardiovasc Surg 1981;81:865-72.
  13. Ovrum E, Tangen G, Tollofsrud S, Oystese R, Ringdal MA, Istad R. Cold blood versus cold crystalloid cardioplegia: a prospective randomised study of 345 aortic valve patients. Eur J Cardiothorac Surg 2010;38:745-9. https://doi.org/10.1016/j.ejcts.2010.03.052
  14. Catinella FP, Cunningham JN Jr, Spencer FC. Myocardial protection during prolonged aortic cross-clamping: comparison of blood and crystalloid cardioplegia. J Thorac Cardiovasc Surg 1984;88:411-23.
  15. Feindel CM, Tait GA, Wilson GJ, Klement P, MacGregor DC. Multidose blood versus crystalloid cardioplegia: comparison by quantitative assessment of irreversible myocardial injury. J Thorac Cardiovasc Surg 1984;87:585-95.
  16. Jacob S, Kallikourdis A, Sellke F, Dunning J. Is blood cardioplegia superior to crystalloid cardioplegia? Interact Cardiovasc Thorac Surg 2008;7:491-8. https://doi.org/10.1510/icvts.2008.178343
  17. Edelman JJ, Seco M, Dunne B, et al. Custodiol for myocardial protection and preservation: a systematic review. Ann Cardiothorac Surg 2013;2:717-28.
  18. Chitwood WR Jr. Retrograde cardioplegia: current methods. Ann Thorac Surg 1992;53:352-5. https://doi.org/10.1016/0003-4975(92)91353-B
  19. Salerno TA, Chiong MA. Should ventricular fibrillation be induced prior to the infusion of cardioplegic solution? Ann Thorac Surg 1983;35:367-71. https://doi.org/10.1016/S0003-4975(10)61586-X

Cited by

  1. Investigating the physiology of normothermic ex vivo heart perfusion in an isolated slaughterhouse porcine model used for device testing and training vol.19, pp.1, 2015, https://doi.org/10.1186/s12872-019-1242-9